electroCore to Participate in the JMP Securities MedTech Bio Summit

electroCore, a bioelectronic medicine company, will have CEO Dan Goldberger participate in a fireside chat at the JMP Securities MedTech Bio Summit on October 1, 2020, at 2:00 PM ET.

Rhea-AI Summary

electroCore, a bioelectronic medicine company, will have CEO Dan Goldberger participate in a fireside chat at the JMP Securities MedTech Bio Summit on October 1, 2020, at 2:00 PM ET. This virtual event will be accessible via a live webcast, furthering the company's outreach and engagement with investors.

electroCore focuses on non-invasive vagus nerve stimulation therapies, currently targeting migraine and cluster headache treatments. For more details, visit www.electrocore.com.

Argus Session date unavailable

-1.80% session move Open Argus

Details

News Market Reaction – ECOR

The recorded move for ECOR in the trading session of this news was -1.80%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief executive officer, will participate in a fireside chat at the JMP Securities MedTech Bio Summit, which is being held virtually October 1-2, 2020.

Event details:

Date: Thursday, October 1, 2020
Time: 2:00pm ET

Audio from the event will be webcast live and available here or on the Investors section of the company’s website.

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:
Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:
Jackie Dorsky
electroCore
973-290-0097

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Dan Goldberger speak at the JMP Securities MedTech Bio Summit?

Dan Goldberger will speak at the JMP Securities MedTech Bio Summit on October 1, 2020, at 2:00 PM ET.

How can I listen to the electroCore webcast?

You can listen to the electroCore webcast live on October 1, 2020, by visiting the company's website or through the provided link in the press release.

What therapies does electroCore focus on?

electroCore focuses on non-invasive vagus nerve stimulation therapies for migraine and cluster headache treatments.

What is the significance of the JMP Securities MedTech Bio Summit for electroCore?

The JMP Securities MedTech Bio Summit provides electroCore an opportunity to engage with investors and present updates on its therapies and strategies.